Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SMAD‑6, ‑7 and ‑9 are potential molecular biomarkers for the prognosis in human lung cancer

9 Jul 2020

Abstract excerpt

SMADs, a family of proteins that function as signal transducers and transcriptional regulators to regulate various signaling pathways, including the transforming growth factor‑β signaling pathway, are similar to the mothers against decapentaplegic family of genes and the sma gene family in Caenorhabditis elegans. SMADs generate context‑dependent modulation by interacting with various sequence‑specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Mechanisms of cancer metastasis
Share to TGF-β signaling in diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32782581
DOI: 10.3892/ol.2020.11851

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SMAD‑6, ‑7 and ‑9 are potential molecular biomarkers for the prognosis in human lung cancerPMID 32782581Read ↗

Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer.Semantic proximity Read ↗

SMAD4 mutation correlates with poor prognosis in non-small cell lung cancer.Semantic proximity Read ↗

Exploring Smad5: a review to pave the way for a deeper understanding of the pathobiology of common respiratory diseasesSemantic proximity Read ↗

SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical ApplicationsSemantic proximity Read ↗

SMAD6 Contributes to Patient Survival in Non–Small Cell Lung Cancer and Its Knockdown Reestablishes TGF-β Homeostasis in Lung Cancer CellsSemantic proximity Read ↗

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical SignificanceSemantic proximity Read ↗

The Dual Role of Smad7 in the Control of Cancer Growth and MetastasisSemantic proximity Read ↗

Correlation Between SMADs and Colorectal Cancer Expression, Prognosis, and Immune InfiltratesSemantic proximity Read ↗

HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axisSemantic proximity Read ↗

RGS6 suppresses TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4Semantic proximity Read ↗

Comprehensive analysis of clinical significance and potential molecular mechanism of PAX gene family in lung squamous cell carcinomaSemantic proximity Read ↗

The immune regulation and therapeutic potential of the SMAD gene family in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.